Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Radiation
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseRadiationC57Bl/6n = Not stated per group; five mice were irradiated in parallel…Injection in 100 uL PBS; exact route not stated200 ug per injection in 100 uL PBS for the three pre-irradi…Pretreatment 4 days before, 2 days before and immediately before irradiation
Model: Full thoracic X-ray irradiation, single dose of 20 Gy at 170 cGy/min, with head, neck, abdomen and lower body shielded by a custom lead cylinder; control animals received 0 Gy
Adding anti-PD-1 antibody to thoracic irradiation reduced 21-day survival from 70 per cent to 36 per cent (p=0.0169) and significantly increased T cell infiltration into heart and lung tissue
Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.